Drug Side Effects
Search
CUTANEOUS T-CELL LYMPHOMA STAGE II
CUTANEOUS T-CELL LYMPHOMA STAGE II
was reported 22 times
These drug classes are most commonly taken by patients reporting CUTANEOUS T-CELL LYMPHOMA STAGE II:
#
Drug
Count
0
Interleukin-4 Receptor alpha Antagonist [EPC]
8
1
Folate Analog Metabolic Inhibitor [EPC]
7
2
Corticosteroid [EPC]
4
3
Retinoid [EPC]
4
4
Tumor Necrosis Factor Blocker [EPC]
4
5
Interleukin-17A Antagonist [EPC]
3
6
Alkylating Drug [EPC]
2
7
Calcineurin Inhibitor Immunosuppressant [EPC]
2
8
Janus Kinase Inhibitor [EPC]
2
9
Sulfone [EPC]
2
10
Vitamin B12 [EPC]
2
11
Vitamin C [EPC]
2
12
Vitamin D [EPC]
2
13
CD20-directed Cytolytic Antibody [EPC]
1
14
CD30-directed Immunoconjugate [EPC]
1
15
GLP-1 Receptor Agonist [EPC]
1
16
Histone Deacetylase Inhibitor [EPC]
1
17
Selective T Cell Costimulation Modulator [EPC]
1
18
Tetracycline-class Drug [EPC]
1